Group
Rare Diseases
4 themes21 tickers
10D rank#8of 129 groups
Peek into the magic of rare disease healthcare. Our group splits into gene, RNA, and protein therapy themes, plus CNS/neuro breakthroughs. With supportive policies and expanding patient access, this market is buzzing with innovative platforms and growth.
Themes in this group
Build 20260710T074722
| Rare Diseases '25: Platform Biotechs & Pipelines | 4 | $28.00B | $112.01B | +0.75% | +4.21% | +8.72% | +8.18% | +25.51% | +88.10% | +118.29% | +91.32% | +21.40% | +101.28% | -3.92% | +44.69% |
| Rare Diseases '25: CNS/Neuro | 5 | $28.52B | $142.61B | -0.69% | +1.27% | +6.45% | +4.01% | +43.74% | +86.34% | +49.72% | +78.44% | +24.19% | +115.83% | -0.08% | +20.10% |
| Rare Diseases '25: RNA Therapy & Protein Mod | 5 | $12.11B | $60.57B | +0.25% | -3.61% | +4.74% | +3.92% | -10.49% | +41.59% | +29.37% | +129.62% | -0.18% | +67.72% | -7.80% | +14.30% |
| Rare Diseases '25: Gene Therapy & Genetic Med | 7 | $4.18B | $29.28B | -0.02% | -0.34% | +3.40% | +2.41% | +47.85% | +68.38% | +33.51% | -31.92% | +45.92% | +67.19% | +4.47% | +30.27% |
Default: 10D ↓ · Click headers to sort · Shift+click secondary